{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:46:45Z","timestamp":1791082005298,"version":"4.1.0"},"reference-count":247,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.critrevonc.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T23:18:01Z","timestamp":1372979881000},"page":"338-356","source":"Crossref","is-referenced-by-count":53,"title":["Essentials of circulating tumor cells for clinical research and practice"],"prefix":"10.1016","volume":"88","author":[{"given":"Marian","family":"Liberko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Kolostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bobek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2013.05.002_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000147848","article-title":"Epithelial\u2013mesenchymal transitions in cancer progression","volume":"156","author":"Birchmeier","year":"1996","journal-title":"Acta Anatomica (Basel)"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00418-008-0464-1","article-title":"Molecular and pathological signatures of epithelial\u2013mesenchymal transitions at the cancer invasive front","volume":"130","author":"De Wever","year":"2008","journal-title":"Histochemistry and Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial\u2013mesenchymal transitions: at the crossroads of developement and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Developmental Cell"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial\u2013mesenchymal transition in cancer developement and its clinical significance","volume":"101","author":"Ivatsuki","year":"2009","journal-title":"Cancer Science"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0025","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2009.080545","article-title":"Epithelial\u2013mesenchymal transition: a cancer research's conceptual friend and foe","volume":"174","author":"Klymkowski","year":"2009","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","article-title":"Metastasis: recent discoveries and novel treatment strategies","volume":"369","author":"Eccles","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the seed and soil hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0045","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mod.2003.06.005","article-title":"Mechanisms, mechanics and function of epithelial\u2013mesenchymal transitions in early developement","volume":"120","author":"Shook","year":"2003","journal-title":"Mechanisms of Development"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.05.002_bib0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrm2455","article-title":"Cancer as an overhealing wound: an old hypothesis revisited","volume":"9","author":"Schafer","year":"2008","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial\u2013mesenchymal trasnsitions in tumor progeression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.gde.2009.12.002","article-title":"Circulating tumor cells: a window into cancer biology and metastasis","volume":"20","author":"Maheswaran","year":"2010","journal-title":"Current Opinion in Genetics and Development"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000147748","article-title":"An overview of epithelio-mesenchymal transformation","volume":"154","author":"Hay","year":"1995","journal-title":"Acta Anatomica"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.05.002_bib0075","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","article-title":"Epithelial\u2013mesenchymal transitions in developent and pathologies","volume":"15","author":"Thiery","year":"2003","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0080","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1038\/sj.onc.1206887","article-title":"Expression profiling of epithelial plasticity in tumor progression","volume":"22","author":"Jechlinger","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0085","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature04872","article-title":"New signalis from the invasive front","volume":"441","author":"Christofori","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/32433","article-title":"A casual role for E-cadherin in the transition from adenoma to carcinoma","volume":"392","author":"Perl","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0095","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/302173","article-title":"The tumor-suppressor function of E-cadherin","volume":"63","author":"Semb","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ccr.2006.09.013","article-title":"Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis","volume":"10","author":"Derksen","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0105","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/0008-5472.CAN-06-3401","article-title":"N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation","volume":"67","author":"Hulit","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0110","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1015312119693","article-title":"Molecular mechanisms of detachment-induced apoptosis\u2013anoikis","volume":"7","author":"Grossmann","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0120","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption od epithelial cell\u2013matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"Journal of Cell Biology"},{"issue":"17","key":"10.1016\/j.critrevonc.2013.05.002_bib0125","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1128\/MCB.24.17.7559-7566.2004","article-title":"Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress","volume":"24","author":"Kajita","year":"2004","journal-title":"Mol Cell Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2013.05.002_bib0130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.294104","article-title":"Snail blocks the cell cycle and confers resistance to cell death","volume":"18","author":"Vega","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0135","first-page":"3151","article-title":"The Snail genes as inducers of cell movement and survival: implications in developement and cancer","volume":"132","author":"Barrallo-Gimeno","year":"2005","journal-title":"Developement"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0140","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.1073\/pnas.0902042106","article-title":"SIP1 protein protects cells from DNA damage-induced apoptosis and has indenpendent prognostic value in blader cancer","volume":"106","author":"Sayan","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0145","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1158\/0008-5472.CAN-07-1653","article-title":"Adaptation versus selection: the origins of metastatic behavior","volume":"67","author":"Scheel","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial\u2013mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2005","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0155","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10585-007-9121-7","article-title":"Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal transitions","volume":"25","author":"Barr","year":"2008","journal-title":"Clinical and Experimental Metastasis"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.05.002_bib0160","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1349-7006.2007.00550.x","article-title":"Signaling networks guiding epithelial\u2013mesenchymal transitions during embryogenesis and cancer progression","volume":"98","author":"Moustakas","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0165","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/01.ATV.0000209518.58252.17","article-title":"Pericellular proteases in angiogenesis and vasculogenesis","volume":"26","author":"van Hinsbergh","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0170","series-title":"Matrix metalloproteases and epithelia-to-mesenchymal transition: implications for carcinoma metastasis","first-page":"1","author":"Gilles","year":"2005"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0175","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1593\/neo.91326","article-title":"Regulation of membrane-type 4,atrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis","volume":"11","author":"Huang","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0180","doi-asserted-by":"crossref","first-page":"20318","DOI":"10.1073\/pnas.0910962106","article-title":"Introduction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1","volume":"106","author":"Ota","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0185","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10585-008-9143-9","article-title":"Matrix metalloproteinases stimulate epithelial\u2013mesenchymal transition durin tumor developement","volume":"25","author":"Orlichenko","year":"2008","journal-title":"Clinical and Experimental Metastasis"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0190","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1158\/0008-5472.CAN-07-0575","article-title":"Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial\u2013mesenchymal transition in cancer cells via up-regulation of Twist gene expression","volume":"67","author":"Lo","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1083\/jcb.120.3.767","article-title":"Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line","volume":"120","author":"Boyer","year":"1993","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0200","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/sj.emboj.7601213","article-title":"Hepatocyte growth factore induces cell scattering through MAPK\/Egr-1-mediated up-regulation of Snail","volume":"25","author":"Grotegut","year":"2006","journal-title":"EMBO Journal"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumor progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ncb0407-361","article-title":"NF-kappaB links oestrogen receptor signaling and EMT","volume":"9","author":"Radisky","year":"2007","journal-title":"Nature Cell Biology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial\u2013mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.critrevonc.2011.11.007","article-title":"Therapeutic and prognostic importance of epithelial\u2013mesenchymal transition in liver cancers: insights from experimental models","volume":"83","author":"Ogunwobi","year":"2012","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.136.2.261","article-title":"Tumor dormancy in vivo by prevention of neovascularization","volume":"136","author":"Gimbrone","year":"1972","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0230","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/1952","article-title":"Cancer, angiogenesis and fractals","volume":"4","author":"Baish","year":"1998","journal-title":"Nature Medicine"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0235","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10555-007-9062-2","article-title":"Hypoxia-driven selection of the metastatic phenotype","volume":"26","author":"Sullivan","year":"2007","journal-title":"Cancer and Metastasis Reviews"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0245","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0002-9440(10)63501-8","article-title":"Hypoxia attenuates the expression of E-cadherin via upregulation of SNAIL in ovarian carcinoma cells","volume":"163","author":"Imai","year":"2003","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/MCB.00892-06","article-title":"VHL promotes E2 box dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail","volume":"27","author":"Evans","year":"2007","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0255","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1634\/stemcells.2007-0724","article-title":"Hypoxia enhancess tumor stemness by increasing the invasive and tumorigenic side population fraction","volume":"26","author":"Das","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0260","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","article-title":"The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype","volume":"8","author":"Heddleston","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0265","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1242\/jcs.01145","article-title":"Snail an E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo","volume":"117","author":"Peinado","year":"2004","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0270","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/ijc.24263","article-title":"Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435 cells through the up-regulation of membrane type-1 matrix metalloproteinase","volume":"124","author":"Kuo","year":"2009","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0275","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1111\/j.1582-4934.2009.00764.x","article-title":"Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumor vasculature architecture","volume":"13","author":"Chabottaux","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0280","first-page":"2347","article-title":"Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation","volume":"29","author":"Peyri","year":"2009","journal-title":"Anticancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0285","first-page":"1803","article-title":"Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells","volume":"25","author":"Ziegelschmidt","year":"2005","journal-title":"Anticancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0290","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/10408360590913696","article-title":"Detection of disseminated tumor cells in peripheral blood","volume":"42","author":"Ziegelschmidt","year":"2005","journal-title":"Critical Reviews in Clinical Laboratory Sciences"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0295","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/scbi.2001.0388","article-title":"Occult micrometastasis: enrichment, identification and characterization of single disseminated tumor cells","volume":"11","author":"Pantel","year":"2001","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0300","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0305","first-page":"465","article-title":"Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay","volume":"23","author":"Demel","year":"2004","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/MB:34:1:15","article-title":"Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment","volume":"34","author":"Lankiewicz","year":"2006","journal-title":"Molecular Biotechnology"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.05.002_bib0315","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1073\/pnas.0813188106","article-title":"Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device","volume":"106","author":"Talasaz","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib0320","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/ijc.26111","article-title":"Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select\/Detect\u2122 versus Veridex CellSearch\u2122 system","volume":"130","author":"Andreopoulou","year":"2012","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib0325","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/bcr3243","article-title":"Prognostic impact of circulating tumor cells assessed with the CellSearch Assay\u2122 and AdnaTest Breast\u2122 in metastatic breast cancer patients: the DETECT study","volume":"14","author":"Muller","year":"2012","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0330","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial\u2013mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0340","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","article-title":"Stem cell and epithelial\u2013mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients","volume":"11","author":"Aktas","year":"2009","journal-title":"Breast Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0345","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2896","article-title":"Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients","volume":"13","author":"Kallergi","year":"2011","journal-title":"Breast Cancer Research"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib0350","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrclinonc.2010.171","article-title":"Molecular mechanisms of metastasis in breast cancer\u2014clinical applications","volume":"7","author":"Mego","year":"2010","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)64706-2","article-title":"Isolation by size of epithelial tumor cells: a new method for immunomorphological and molecular characterisation of circulatin tumor cells","volume":"156","author":"Vona","year":"2000","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2303.2010.00835.x","article-title":"Morphological analysis of circulating tumor cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumor cell (ISET) method","volume":"23","author":"Hofman","year":"2012","journal-title":"Cythopatology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0365","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2006.12.014","article-title":"Circulating tumor cells (CTC) detection: clinical impact and future directions","volume":"253","author":"Paterlini-Brechot","year":"2007","journal-title":"Cancer Letters"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0370","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/1078-0432.CCR-10-0445","article-title":"Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker","volume":"17","author":"Hofman","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0375","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ijc.25819","article-title":"Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch assay\u2122 and the isolation by size of epithelial tumor cell method","volume":"129","author":"Hofman","year":"2011","journal-title":"Interantional Journal of Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0380","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/bjc.2011.405","article-title":"Detection of circulating tumour cells with a hybrid (epithelial\/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer","volume":"105","author":"Lecharpentier","year":"2011","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib0385","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JTO.0b013e31823c5c16","article-title":"Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches","volume":"7","author":"Krebs","year":"2012","journal-title":"Journal of Thoracic Oncology"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.05.002_bib0390","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1158\/1541-7786.MCR-10-0490","article-title":"Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers","volume":"9","author":"Armstrong","year":"2011","journal-title":"Molecular Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0395","doi-asserted-by":"crossref","first-page":"e16186","DOI":"10.1371\/journal.pone.0016186","article-title":"Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity","volume":"6","author":"Strauss","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib0400","first-page":"427","article-title":"A new device for rapid isolation and characterisation of rare circulating tumor cells","volume":"31","author":"Dessiter","year":"2011","journal-title":"Anticancer Research"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.05.002_bib0405","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/bjc.2011.294","article-title":"A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas","volume":"105","author":"Farace","year":"2011","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0410","doi-asserted-by":"crossref","first-page":"e33788","DOI":"10.1371\/journal.pone.0033788","article-title":"Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer celllines","volume":"7","author":"Powell","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0415","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ctrv.2009.03.004","article-title":"Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer","volume":"35","author":"Mostert","year":"2009","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cyto.b.20065","article-title":"Comparison of two methods for enumerating circulating tumor cells in carcinoma patients","volume":"68","author":"Balic","year":"2005","journal-title":"Cytometry Part B: Clinical Cytometry"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0425","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-642-59349-9_13","article-title":"Detection of circulating tumor cells in bloof using an optimized density gradient centrifugation","volume":"162","author":"Gertler","year":"2003","journal-title":"Recent Results in Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0430","doi-asserted-by":"crossref","first-page":"34119","DOI":"10.1063\/1.3623748","article-title":"Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device","volume":"5","author":"Dickinson","year":"2011","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0435","first-page":"252361","article-title":"Detection of EpCAM-negatove and cytokeratin-negative circulating tumor cells in peripheral blood","author":"Mikolajczyk","year":"2011","journal-title":"Journal of Oncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib0440","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1158\/2159-8290.CD-11-0215","article-title":"A novel platform for detection of CK+ and CK\u2212 CTCs","volume":"1","author":"Pecot","year":"2011","journal-title":"Cancer Discovery"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib0445","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cancergen.2011.10.011","article-title":"FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE\u2122 platform","volume":"204","author":"Mayer","year":"2011","journal-title":"Cancer Genetics"},{"issue":"7173","key":"10.1016\/j.critrevonc.2013.05.002_bib0450","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","article-title":"Isolation of rare circulating tumour cells in cancer patients by microchip technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0455","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMoa0800668","article-title":"Detection of mutations in EGFR in circulating lung-cancer cells","volume":"359","author":"Maheswaran","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"25","key":"10.1016\/j.critrevonc.2013.05.002_bib0460","doi-asserted-by":"crossref","first-page":"25ra23","DOI":"10.1126\/scitranslmed.3000403","article-title":"Isolation and characterisation of circulating tumor cells from localized and metastatic prostate cancer patients","volume":"2","author":"Stott","year":"2010","journal-title":"Science Translational Medicine"},{"issue":"43","key":"10.1016\/j.critrevonc.2013.05.002_bib0465","doi-asserted-by":"crossref","first-page":"18392","DOI":"10.1073\/pnas.1012539107","article-title":"Isolation of circulating tumor cells using a microvortex-generating herringbone chip","volume":"107","author":"Stott","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"20","key":"10.1016\/j.critrevonc.2013.05.002_bib0470","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/1078-0432.CCR-10-1105","article-title":"Portable filter-based microdevice for detection and characterization of circulating tumor cells","volume":"16","author":"Lin","year":"2010","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2010.04.008","article-title":"Disseminated and circulating tumor cells: role in effective cancer management","volume":"77","author":"Lin","year":"2011","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0480","doi-asserted-by":"crossref","first-page":"016003","DOI":"10.1088\/1478-3975\/9\/1\/016003","article-title":"Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers","volume":"9","author":"Marrinucci","year":"2012","journal-title":"Physical Biology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0485","doi-asserted-by":"crossref","first-page":"010301","DOI":"10.1088\/1478-3975\/9\/1\/010301","article-title":"A fluid biopsy as investigating technology for the solid phase of solid tumors","volume":"9","author":"Kuhn","year":"2012","journal-title":"Physical Biology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0490","first-page":"96","article-title":"Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient","volume":"2","author":"Phillips","year":"2012","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0495","first-page":"72","article-title":"Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient","volume":"2","author":"Phillips","year":"2012","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0500","doi-asserted-by":"crossref","first-page":"016001","DOI":"10.1088\/1478-3975\/9\/1\/016001","article-title":"Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors","volume":"9","author":"Cho","year":"2012","journal-title":"Physical Biology"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0505","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2478\/v10042-008-0042-3","article-title":"Aggregation formation mediated anoikis resistance of BEL7402 hepatoma cells","volume":"46","author":"Zhang","year":"2008","journal-title":"Folia Histochemica et Cytobiologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0510","doi-asserted-by":"crossref","first-page":"016004","DOI":"10.1088\/1478-3975\/9\/1\/016004","article-title":"High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis","volume":"9","author":"Nieva","year":"2012","journal-title":"Physical Biology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0515","doi-asserted-by":"crossref","first-page":"016005","DOI":"10.1088\/1478-3967\/9\/1\/016005","article-title":"Fluid biopsy for circulating tumor cell identification in patients with early- and late-stage non-small cell lunf cancer: a glimpse into lung cancer biology","volume":"9","author":"Wendel","year":"2012","journal-title":"Physical Biology"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2013.05.002_bib0520","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jim.2005.02.007","article-title":"Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients","volume":"299","author":"Alix-Panabi\u00e9res","year":"2005","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0525","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1373\/clinchem.2006.079509","article-title":"Detection and characterization of putative metastatic precursor cells in cancer patients","volume":"53","author":"Alix-Panabi\u00e9res","year":"2007","journal-title":"Clinical Chemistry"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0530","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr2326","article-title":"Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer","volume":"11","author":"Alix-Panabi\u00e9res","year":"2009","journal-title":"Breast Cancer Research"},{"issue":"28","key":"10.1016\/j.critrevonc.2013.05.002_bib0535","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1073\/pnas.0703875104","article-title":"In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry","volume":"104","author":"He","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0540","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nnano.2009.333","article-title":"In vivo magnetic enrichemnt and multiplex photoacoustic detection of circulating tumor cells","volume":"4","author":"Galanzha","year":"2009","journal-title":"Nature Nanotechnology"},{"issue":"20","key":"10.1016\/j.critrevonc.2013.05.002_bib0545","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1158\/0008-5472.CAN-08-4900","article-title":"In vivo, non-invasive, label-free detection and erradication of circulating metastatic melanoma cells using two-color photoacustic flow cytometry with diode laser","volume":"69","author":"Galanzha","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0550","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2008.12.007","article-title":"Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer","volume":"277","author":"Paris","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0555","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.24814","article-title":"Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients","volume":"126","author":"Lu","year":"2010","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0560","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1039\/B917959C","article-title":"Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody","volume":"10","author":"Glenhorn","year":"2010","journal-title":"Lab Chip"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib0565","doi-asserted-by":"crossref","first-page":"e35976","DOI":"10.1371\/journal.pone.0035976","article-title":"Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device","volume":"7","author":"Kirby","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0570","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1373\/clinchem.2011.176669","article-title":"Microtube device for selectin-mediated capture of viable circulating tumor cells from blood","volume":"58","author":"Hughes","year":"2012","journal-title":"Clinical Chemistry"},{"issue":"64","key":"10.1016\/j.critrevonc.2013.05.002_bib0575","first-page":"e4248","article-title":"Rapid isolation of viable circulating tumor cells from patient blood samples","author":"Hughes","year":"2012","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0580","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-5876-10-138","article-title":"Considerations in the development of circulating tumor cell technology for clinical use","volume":"10","author":"Parkinson","year":"2012","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0585","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-642-28160-0_18","article-title":"CTCs in metastatic breast cancer","volume":"195","author":"Giordano","year":"2012","journal-title":"Recent Results in Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0590","doi-asserted-by":"crossref","first-page":"e15624","DOI":"10.1371\/journal.pone.0015624","article-title":"HER2-positive circulating tumor cells in breast cancer","volume":"6","author":"Ignatiadis","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0595","first-page":"1111","article-title":"Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer","volume":"21","author":"Hayes","year":"2002","journal-title":"International Journal of Oncology"},{"issue":"25","key":"10.1016\/j.critrevonc.2013.05.002_bib0600","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1073\/pnas.0402993101","article-title":"HER-2 gene amplification can be acquired as breast cancer progresses","volume":"101","author":"Meng","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0605","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/bcr1783","article-title":"Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status","volume":"9","author":"Fehm","year":"2007","journal-title":"Breast Cancer Research"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib0610","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-010-1163-x","article-title":"HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial","volume":"124","author":"Fehm","year":"2010","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0615","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-009-0461-7","article-title":"Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients","volume":"118","author":"Pestrin","year":"2009","journal-title":"Breast Cancer Research and Treatment"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0620","doi-asserted-by":"crossref","first-page":"e12517","DOI":"10.1371\/journal.pone.0012517","article-title":"Molecular biomarker analyses using circulating tumor cells","volume":"5","author":"Punnoose","year":"2010","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0625","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/1078-0432.CCR-09-2042","article-title":"Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial","volume":"16","author":"Riethdorf","year":"2010","journal-title":"Clinical Cancer Research"},{"issue":"18(20)","key":"10.1016\/j.critrevonc.2013.05.002_bib0630","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1158\/1078-0432.CCR-12-1585","article-title":"Challenges in the enumeration and phenotyping of CTC","volume":"15","author":"Coumans","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0635","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-642-28160-0_16","article-title":"CTCs in primary breast cancer (I)","volume":"195","author":"Rack","year":"2012","journal-title":"Recent Results in Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0640","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1379-4","article-title":"The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature","volume":"130","author":"Zhao","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"issue":"20","key":"10.1016\/j.critrevonc.2013.05.002_bib0645","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-12-1587","article-title":"Meta-analysis of the prognostic value of circulating tumor cells in breast cancer","volume":"18","author":"Zhang","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.05.002_bib0650","first-page":"2629","article-title":"A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients \u2013 a meta-analysis","volume":"12","author":"Wang","year":"2011","journal-title":"Asian Pacific journal of cancer prevention"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0655","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2011.05.004","article-title":"Circulating tumor cells in prostate cancer: a potential surrogate marker of survival","volume":"81","author":"Doyen","year":"2012","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib0660","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.7314\/APJCP.2012.13.4.1137","article-title":"Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer","volume":"13","author":"Ma","year":"2012","journal-title":"Asian Pacific journal of cancer prevention"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib0665","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.bjc.6605413","article-title":"Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients","volume":"101","author":"Mego","year":"2009","journal-title":"British Journal of Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0670","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","article-title":"Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation","volume":"6","author":"Davila","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0675","first-page":"01501","article-title":"Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells","volume":"8","author":"Berni-Lang","year":"2011","journal-title":"Physical Biology"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib0680","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/j.1538-7836.2007.02766.x","article-title":"Elevated tissue factor procoagulant activity in CD133-positive cancer cells","volume":"5","author":"Milsom","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib0685","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/ATVBAHA.108.177444","article-title":"Tissue factor and cancer stem cells: is there a linkage?","volume":"29","author":"Milsom","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"24","key":"10.1016\/j.critrevonc.2013.05.002_bib0690","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.1158\/0008-5472.CAN-08-2067","article-title":"Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis","volume":"68","author":"Milsom","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0695","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fonc.2012.00115","article-title":"Do circulating tumor cells play a role in coagulation and thrombosis?","volume":"2","author":"Tormoen","year":"2012","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0700","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fonc.2012.00110","article-title":"Development of coagulation factor probes for the identification of procoagulant circulating tumor cells","volume":"2","author":"Tormoen","year":"2012","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0705","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial\u2013mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0710","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10911-009-9110-3","article-title":"The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies","volume":"14","author":"Hollier","year":"2009","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib0715","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejca.2010.02.030","article-title":"Cancer stemness and metastasis: therapeutic consequences and perspectives","volume":"46","author":"Monteiro","year":"2010","journal-title":"European Journal of Cancer"},{"issue":"6024","key":"10.1016\/j.critrevonc.2013.05.002_bib0720","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0725","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib0730","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"43","key":"10.1016\/j.critrevonc.2013.05.002_bib0735","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1038\/sj.onc.1207947","article-title":"Self-renewal and solid tumor stem cells","volume":"23","author":"Al-Hajj","year":"2004","journal-title":"Oncogene"},{"issue":"6464","key":"10.1016\/j.critrevonc.2013.05.002_bib0740","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature."},{"issue":"7123","key":"10.1016\/j.critrevonc.2013.05.002_bib0745","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumor growth in immunodeficient mice","volume":"445","author":"O\u2019Brien","year":"2007","journal-title":"Nature"},{"issue":"7015","key":"10.1016\/j.critrevonc.2013.05.002_bib0750","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumor initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"issue":"7123","key":"10.1016\/j.critrevonc.2013.05.002_bib0755","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.09.037","article-title":"Medulloblastoma cells that express CD133+ are radioresistant relative to CD133\u2212 cells, and the CD133+ sector is enlarged by hypoxia","volume":"67","author":"Blazek","year":"2007","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0765","first-page":"201","article-title":"Biological significance of tumor buddin at the invasive front of human colorectal carcinoma cells","volume":"41","author":"Yusra","year":"2012","journal-title":"International Journal of Oncology"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib0770","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"CHT-resistant human AML stem cells home to and engraft within bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0775","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression of CD133+ cancer stem cells in glioblastoma","volume":"5","author":"Liu","year":"2006","journal-title":"Molecular Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0780","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to CHT","volume":"100","author":"Li","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0785","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cancer Stem Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.05.002_bib0790","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 regulates self renewal and tumorigenicity of breast cancer cells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib0795","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr1982","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive CHT","volume":"10","author":"Fillmore","year":"2008","journal-title":"Breast Cancer Research"},{"issue":"24","key":"10.1016\/j.critrevonc.2013.05.002_bib0800","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24(\u2212\/low)\/CD44+ breast cancer-initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib0805","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.26037","article-title":"Expression of epithelial\u2013mesenchymal transition-inducing transcription factors in primary breast cancer: the effect of neoadjuvant therapy","volume":"130","author":"Mego","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0810","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7150\/jca.5111","article-title":"Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose CHT with autologous hematopoietic stem cell transplantation","volume":"3","author":"Mego","year":"2012","journal-title":"Journa of Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0815","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-08-2372","article-title":"Twist1-mediated Adriamycin induced epithelial\u2013mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells","volume":"15","author":"Li","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0820","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humpath.2011.05.005","article-title":"CD44+\/CD24\u2212\/low cancer stem\/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome","volume":"43","author":"Idowu","year":"2012","journal-title":"Human Pathology"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib0825","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1535-7163.MCT-12-0460","article-title":"Epithelial\u2013mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer","volume":"11","author":"Giordano","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.05.002_bib0830","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.ejca.2011.01.011","article-title":"Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype","volume":"47","author":"Reuben","year":"2011","journal-title":"European Journal of Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib0835","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1158\/1078-0432.CCR-08-1479","article-title":"Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based CHT for breast cancer","volume":"15","author":"Tanei","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0840","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-009-0619-3","article-title":"Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment","volume":"123","author":"Resetkova","year":"2010","journal-title":"Breast Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib0845","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/annonc\/mdq323","article-title":"Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization","volume":"22","author":"Gradilone","year":"2011","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib0850","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","article-title":"Cancer stem cells","volume":"355","author":"Jordan","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.05.002_bib0855","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/0091270005276905","article-title":"Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis","volume":"45","author":"Donnenberg","year":"2005","journal-title":"Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0860","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.seminoncol.2003.08.015","article-title":"Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists","volume":"30","author":"Wang","year":"2003","journal-title":"Seminars in Oncology"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.05.002_bib0865","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ijc.11479","article-title":"Detection of breast cancer cells in the peripheral blood is positively correlated wit estrogen-receptor status and predicts for poor prognosis","volume":"107","author":"Gaforio","year":"2003","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0870","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib0875","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1200\/JCO.2005.08.140","article-title":"Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer","volume":"23","author":"Cristofanilli","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib0880","first-page":"179","article-title":"Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer","volume":"13","author":"Bauernhofer","year":"2005","journal-title":"Oncology Reports"},{"issue":"21","key":"10.1016\/j.critrevonc.2013.05.002_bib0885","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1158\/1078-0432.CCR-05-1769","article-title":"Circulating tumor cells versus imaging - predicting overall survival in metastatic breast cancer","volume":"12","author":"Budd","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0890","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-05-2821","article-title":"Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overal survival","volume":"12","author":"Hayes","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0895","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1200\/JCO.2005.04.5948","article-title":"Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients","volume":"24","author":"Xenidis","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.05.002_bib0900","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/annonc\/mdm208","article-title":"Clinical relevance of circulating CK-19 mRNA-positve cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer","volume":"18","author":"Xenidis","year":"2007","journal-title":"Annals of Oncology"},{"issue":"33","key":"10.1016\/j.critrevonc.2013.05.002_bib0905","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2007.11.7762","article-title":"Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2-status in early-stage breast cancer","volume":"25","author":"Ignatiadis","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0910","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/cncr.23852","article-title":"Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?","volume":"113","author":"Dawood","year":"2008","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.05.002_bib0915","first-page":"2593","article-title":"Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer","volume":"14","author":"Igniatiadis","year":"2008","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib0920","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/annonc\/mdm558","article-title":"Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications","volume":"19","author":"Nole","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0925","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-08-0030","article-title":"Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant CHT in large operable and locally advanced breast cancer in a phase II randomized trial","volume":"14","author":"Pierga","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0930","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10147-007-0748-9","article-title":"Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional trial in Japan","volume":"13","author":"Yagata","year":"2008","journal-title":"International Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0935","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annonc\/mdp262","article-title":"Circulating tumor cells and bone metastases as detected by FDG-PET\/CT in patients with metastatic breast cancer","volume":"21","author":"De Giorgi","year":"2009","journal-title":"Annals of Oncology"},{"issue":"20","key":"10.1016\/j.critrevonc.2013.05.002_bib0940","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1200\/JCO.2008.19.4423","article-title":"Circulating tumor cells and 18F-Fluorodeoxyglucose positron emission tomography\/computed tomography for outcome prediction in metastatic breast cancer","volume":"27","author":"De Giorgi","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib0945","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/annonc\/mdp207","article-title":"Circulating tumor cells in metastatic inflammatory breast cancer","volume":"20","author":"Mego","year":"2009","journal-title":"Annals of Oncology"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.05.002_bib0950","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4161\/cbt.8.8.7834","article-title":"Detection of circulating tumor cells in the context of treatment: prognostic value in breast cancer","volume":"8","author":"Serrano","year":"2009","journal-title":"Cancer Biology and Therapy"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0955","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-008-0143-x","article-title":"Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies","volume":"115","author":"Tewes","year":"2009","journal-title":"Breast Cancer Research and Treatment"},{"issue":"13","key":"10.1016\/j.critrevonc.2013.05.002_bib0960","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1200\/JCO.2008.18.0497","article-title":"Cytokeratin-19 mRNA-positve circulating tumor cells after adjuvant CHT in patients with early breast cancer","volume":"27","author":"Xenidis","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib0965","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdp391","article-title":"Single circulating tumor cell detection and overall survival in nonmetastic breast cancer","volume":"21","author":"Bidard","year":"2010","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib0970","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-009-0668-7","article-title":"Modeling the relationship between circulating tumor cells number and prognosis of metastatic breast cancer","volume":"122","author":"Botteri","year":"2010","journal-title":"Breast Cancer Research and Treatment"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.05.002_bib0975","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2967\/jnumed.110.076455","article-title":"18F-FDG PET\/CT findings and circulating tumor cells counts in the monitoring of systemic therapies for bone metastases from breast cancer","volume":"51","author":"De Giorgi","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"issue":"31","key":"10.1016\/j.critrevonc.2013.05.002_bib0980","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2008.20.6664","article-title":"Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer","volume":"27","author":"Liu","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib0985","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2011.04.039","article-title":"Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients","volume":"122","author":"Aktas","year":"2011","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.05.002_bib0990","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/030089161109700610","article-title":"Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial","volume":"97","author":"Consoli","year":"2011","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib0995","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr2907","article-title":"Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment","volume":"13","author":"Giuliano","year":"2011","journal-title":"Breast Cancer Research"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib1000","first-page":"979","article-title":"Changing levels of circulating tumor cells in monitoring CHT response in patients with metastatic breast cancer","volume":"31","author":"Hartkopf","year":"2011","journal-title":"Anticancer Research"},{"issue":"13(3)","key":"10.1016\/j.critrevonc.2013.05.002_bib1005","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/bcr2898","article-title":"The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients","volume":"14","author":"Molloy","year":"2011","journal-title":"Breast Cancer Research"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib1010","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-11-0255","article-title":"mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients","volume":"17","author":"Sieuverts","year":"2011","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1015","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/bcr3114","article-title":"Assesment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study","volume":"14","author":"Bidard","year":"2012","journal-title":"Breast Cancer Research"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib1020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clbc.2012.04.004","article-title":"Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer","volume":"12","author":"De Giorgi","year":"2012","journal-title":"Clinical Breast Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib1025","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/annonc\/mds020","article-title":"Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting CHT-resistant CK19 mRNA-positive circulating tumor cells: results of a randomized phase II study","volume":"23","author":"Georgoulias","year":"2012","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib1030","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/annonc\/mdr434","article-title":"Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy","volume":"23","author":"Giordano","year":"2012","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib1035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10147-011-0260-0","article-title":"Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer","volume":"17","author":"Hayashi","year":"2012","journal-title":"International Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4048\/jbc.2012.15.1.34","article-title":"Circulating tumor cells detected by RT-PCR for CK-20 before surgery indicate worse prognostic impact in triple-negative and HER2 subtype breast cancer","volume":"15","author":"Hwang","year":"2012","journal-title":"Journal of Breast Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib1045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1470-2045(12)70209-7","article-title":"Circulating tumour cells in non-metastatic breast cancer: a prospective study","volume":"13","author":"Lucci","year":"2012","journal-title":"Lancet Oncology"},{"issue":"14(4)","key":"10.1016\/j.critrevonc.2013.05.002_bib1050","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/bcr3242","article-title":"Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival","volume":"14","author":"Mathiesen","year":"2012","journal-title":"Breast Cancer Research"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib1055","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/bjc.2012.137","article-title":"Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients","volume":"106","author":"Payne","year":"2012","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib1060","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdr263","article-title":"High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line CHT for metastatic breast cancer patients","volume":"23","author":"Pierga","year":"2012","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib1065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2407-12-190","article-title":"Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome","volume":"28","author":"Tjensvoll","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/etm.2012.540","article-title":"Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy","volume":"4","author":"Serrano","year":"2012","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"19","key":"10.1016\/j.critrevonc.2013.05.002_bib1075","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"22","key":"10.1016\/j.critrevonc.2013.05.002_bib1080","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1158\/1078-0432.CCR-08-0290","article-title":"Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial","volume":"14","author":"Koyanagi","year":"2008","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib1085","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/annonc\/mdp463","article-title":"Circulating tumor cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with CHT and targeted agents","author":"Tol","year":"2010","journal-title":"Annals of Oncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib1090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdn786","article-title":"Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer","volume":"20","author":"Cohen","year":"2009","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib1095","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2010.30.5151","article-title":"Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes'stage B and C colorectal cancer","volume":"29","author":"Iinuma","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib1100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/bjc.2011.40","article-title":"Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse","volume":"104","author":"Lu","year":"2011","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.05.002_bib1105","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1349-7006.2011.01926.x","article-title":"Circulating tumor cells as a surrogate marker for determining response to CHT in Japanese patients with metastatic colorectal cancer","volume":"102","author":"Matsusaka","year":"2011","journal-title":"Cancer Sci"},{"issue":"Oct 1","key":"10.1016\/j.critrevonc.2013.05.002_bib1110","article-title":"Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer","author":"Aggarwal","year":"2012","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1479-5876-10-222","article-title":"Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients","volume":"10","author":"Albuquerque","year":"2012","journal-title":"Journal of Translational Medicine"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.05.002_bib1120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1634\/theoncologist.2012-0048","article-title":"Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line CHT plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study","volume":"17","author":"Sastre","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib1125","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1245\/s10434-011-1889-7","article-title":"Usefulness of transcription-reverse transcription concerted reaction method for detecting circulatin tumor cells in patients with colorectal cancer","volume":"19","author":"Sato","year":"2012","journal-title":"Annals of Surgical Oncology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib1130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3892\/or.2012.1649","article-title":"Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes\u2019 stage B and C colorectal cancer patients","volume":"27","author":"Shimada","year":"2012","journal-title":"Oncology Reports"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.05.002_bib1135","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.urology.2004.11.006","article-title":"Circulating tumor cells predict survival in patients with metastatic prostate cancer","volume":"65","author":"Moreno","year":"2005","journal-title":"Urology"},{"issue":"23","key":"10.1016\/j.critrevonc.2013.05.002_bib1140","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1158\/1078-0432.CCR-07-1506","article-title":"Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer","volume":"13","author":"Danila","year":"2007","journal-title":"Clinical Cancer Research"},{"issue":"19","key":"10.1016\/j.critrevonc.2013.05.002_bib1145","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","article-title":"Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer","volume":"14","author":"De Bono","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib1150","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1158\/1055-9965.EPI-08-1173","article-title":"Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers and Prevention"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib1155","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.juro.2008.11.015","article-title":"Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer","volume":"181","author":"Okegawa","year":"2009","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/annonc\/mdn544","article-title":"Circulating tumor cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience","volume":"20","author":"Olmos","year":"2009","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.critrevonc.2013.05.002_bib1165","first-page":"01049","article-title":"Prognostic significance of circulating tumor cell count in patients with metastatic hormone-sensitive prostate cancer","volume":"October","author":"Resel Folkersma","year":"2012","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2006.11.006","article-title":"CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor","volume":"56","author":"Chen","year":"2007","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib1175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lungcan.2008.05.024","article-title":"Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer","volume":"63","author":"Yie","year":"2009","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.05.002_bib1180","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2010.28.7045","article-title":"Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer","volume":"29","author":"Krebs","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib1185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.lungcan.2010.04.017","article-title":"TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients","volume":"71","author":"Yoon","year":"2011","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.05.002_bib1190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.lungcan.2012.04.005","article-title":"ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy","volume":"77","author":"Das","year":"2012","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.05.002_bib1195","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/annonc\/mds138","article-title":"Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor","volume":"23","author":"Hiltermann","year":"2012","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib1200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib1205","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JTO.0b013e31823f125d","article-title":"Prognostic impact of circulating tumor cells in patients with small cell lung cancer","volume":"7","author":"Naito","year":"2012","journal-title":"Journal of Thoracic Oncology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib1210","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1464-410X.2009.09130.x","article-title":"Prognostic significance of surviving-expressing circulating tumor cells in T1G3 bladder cancer","volume":"106","author":"Gradilone","year":"2010","journal-title":"BJU International"},{"issue":"Feb 28","key":"10.1016\/j.critrevonc.2013.05.002_bib1215","article-title":"Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis","author":"Gazzaniga","year":"2012","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.05.002_bib1220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.05.002_bib1225","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based CHT","volume":"21","author":"Aktas","year":"2011","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.05.002_bib1230","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecologic Oncology"},{"issue":"Sep 24","key":"10.1016\/j.critrevonc.2013.05.002_bib1235","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance \u2013 a study of the OVCAD consortium","author":"Obermayr","year":"2012","journal-title":"Gynecologic Oncology"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T01:53:38Z","timestamp":1563328418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842813000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":247,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1040842813000966"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2013.05.002","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}